DIPHARMA S A has a total of 15 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ALAR PHARMACEUTICALS INC, ALKAHEST INC and OYSTER POINT PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | Italy | 1 | |
#8 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Maccari Giuseppe | 6 |
#2 | Conti Chiara | 5 |
#3 | Giammillari Salvatore Agostino | 5 |
#4 | Pain Gilles | 3 |
#5 | Gelbhart Bareket | 3 |
#6 | Cannata Fabio | 3 |
#7 | Attolino Emanuele | 3 |
#8 | Chiara Conti | 1 |
#9 | Gandhi Anilkumar Surendrakumar | 1 |
#10 | Salvatore Agostino Giammillari | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018158249A1 | Room temperature stable pharmaceutical composition comprising carglumic acid | |
WO2018019931A1 | Pharmaceutical composition kit comprising sapropterin dihydrochloride | |
US9783485B1 | Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof | |
ITUB20160650A1 | PHARMACEUTICAL FORMULATIONS SOLID STABLE CONTAINING 2- (2-NITRO-4-TRIFLUOROMETILBENZOIL) -1,3-CYCLOESANDION |